| P50 | author | Marshall Lightowlers | Q6773683 |
| | Steven G Reed | Q89520964 |
| | William A. Petri | Q27663335 |
| | Alex Loukas | Q30513842 |
| | Jesus G Valenzuela | Q56775666 |
| | Xiaoti Guo | Q66018086 |
| P2093 | author name string | Shaden Kamhawi | |
| | Jeffrey M Bethony | |
| | Rhea N Cole | |
| P2860 | cites work | Entamoeba histolytica phagocytosis of human erythrocytes involves PATMK, a member of the transmembrane kinase family | Q21090527 |
| | Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden | Q21092296 |
| | Liver fluke induces cholangiocarcinoma | Q21092372 |
| | Hookworm-related anaemia among pregnant women: a systematic review | Q21144550 |
| | Chagas disease: an impediment in achieving the Millennium Development Goals in Latin America | Q21254563 |
| | Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs | Q21563438 |
| | The genome of the blood fluke Schistosoma mansoni | Q22122228 |
| | The Schistosoma japonicum genome reveals features of host-parasite interplay | Q22122229 |
| | The antipoverty vaccines | Q24290719 |
| | Rescuing the bottom billion through control of neglected tropical diseases | Q24290723 |
| | Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum | Q24534649 |
| | Entamoeba histolytica infection in children and protection from subsequent amebiasis | Q24537379 |
| | Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen | Q24597151 |
| | Disease and Development: Evidence from Hookworm Eradication in the American South | Q24607787 |
| | Helminth infections: the great neglected tropical diseases | Q24648324 |
| | Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine | Q24655529 |
| | Current status of vaccines for schistosomiasis | Q24657733 |
| | The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response | Q24657806 |
| | "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor | Q24810845 |
| | Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria | Q25256957 |
| | Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil | Q27306739 |
| | An annotated catalogue of salivary gland transcripts in the adult female mosquito, Aedes aegypti | Q27478018 |
| | Hyaluronidase of Bloodsucking Insects and Its Enhancing Effect on Leishmania Infection in Mice | Q27486947 |
| | SAAG-4 is a novel mosquito salivary protein that programmes host CD4+T cells to express IL-4 | Q27489884 |
| | Insight into the sialome of the Black Fly, Simulium vittatum | Q27490406 |
| | An insight into the sialome of Glossina morsitans morsitans | Q27491348 |
| | X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus | Q27646442 |
| | Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate | Q27653441 |
| | The immunology of susceptibility and resistance to Leishmania major in mice | Q34988360 |
| | Resistance of Schistosoma mansoni to praziquantel: is there a problem? | Q35021630 |
| | Progress in control of hydatidosis using vaccination--a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes | Q35073501 |
| | The impact of chemotherapy on morbidity due to schistosomiasis | Q35126805 |
| | Animal models for the analysis of immune responses to leishmaniasis | Q35188674 |
| | Development of a leishmaniasis vaccine: the importance of MPL. | Q35192190 |
| | Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response | Q35217499 |
| | Schistosomiasis control: keep taking the tablets. | Q35640594 |
| | Helminth parasites--masters of regulation | Q35884205 |
| | Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells | Q35947234 |
| | Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. | Q35989214 |
| | Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? | Q36056272 |
| | Schistosomes: the road from host-parasite interactions to vaccines in clinical trials | Q36056288 |
| | Second-generation vaccines against leishmaniasis | Q36101424 |
| | Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant | Q36141819 |
| | Immunity induced by the radiation-attenuated schistosome vaccine | Q36247360 |
| | Neurocysticercosis: updated concepts about an old disease | Q36259999 |
| | Leptospirosis vaccines: past, present, and future. | Q36333300 |
| | Prevalence and incidence of Entamoeba histolytica infection in South Africa and Egypt | Q36354569 |
| | Recombinant interleukin 12 cures mice infected with Leishmania major | Q36361742 |
| | Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response | Q36361808 |
| | A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. | Q36364671 |
| | Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein | Q36369425 |
| | Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis | Q36401312 |
| | The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission | Q36423181 |
| | Drug resistance in amoebiasis. | Q36436461 |
| | New technologies for the control of human hookworm infection | Q36482272 |
| | Is it possible to develop pan-arthropod vaccines? | Q36511466 |
| | Hookworm vaccines: past, present, and future | Q36635886 |
| | Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. | Q36678092 |
| | Schistosome membrane proteins as vaccines | Q36707894 |
| | Cestode vaccines: origins, current status and future prospects. | Q36726734 |
| | Vaccines against blood-feeding nematodes of humans and livestock | Q36726742 |
| | Artemisinins for schistosomiasis and beyond. | Q36747308 |
| | The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus | Q42626863 |
| | Empowering women and improving female reproductive health through control of neglected tropical diseases | Q42630557 |
| | "Manifesto" for advancing the control and elimination of neglected tropical diseases | Q42770755 |
| | Neglected diseases and poverty in "The Other America": the greatest health disparity in the United States? | Q42868433 |
| | A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis | Q42945323 |
| | The giant anteater in the room: Brazil's neglected tropical diseases problem | Q43073106 |
| | Black fly salivary gland extract inhibits proliferation and induces apoptosis in murine splenocytes | Q43096455 |
| | Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis | Q43109540 |
| | Epidemiologic features of equine Leptospira interrogans of human significance | Q43214164 |
| | Vaccination of pigs to control human neurocysticercosis | Q43218919 |
| | Can schistosomiasis really be consigned to history without a vaccine? | Q43361070 |
| | A strategy to control transmission of Schistosoma japonicum in China | Q43367057 |
| | Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel | Q43550539 |
| | Vaccine strategies against schistosomiasis: from concepts to clinical trials | Q43578478 |
| | Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent | Q43614701 |
| | Immunoglobulins associated with passive transfer of resistance to Taenia taeniaeformis in the mouse | Q43684741 |
| | Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren | Q43950575 |
| | Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. | Q43954184 |
| | The diagnosis of hookworm disease;. | Q44940555 |
| | Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia | Q45382040 |
| | Vaccination against ovine cysticercosis using a defined recombinant antigen | Q45764057 |
| | Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine | Q46214496 |
| | Potential eradicability of taeniasis and cysticercosis. | Q46615605 |
| | Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis | Q46711852 |
| | Necator americanus: optimization of the golden hamster model for testing anthelmintic drugs | Q46730808 |
| | Expression of yellow jacket and wasp venom Ag5 allergens in bacteria and in yeast. | Q46767336 |
| | Proteins exposed at the adult schistosome surface revealed by biotinylation | Q46790359 |
| | Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour | Q46898070 |
| | The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction | Q46919769 |
| | Helminths, allergic disorders and IgE-mediated immune responses: where do we stand? | Q34620969 |
| | The immunobiology of schistosomiasis | Q34718128 |
| | Vaccines for leishmaniasis in the fore coming 25 years. | Q34754538 |
| | Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults | Q34768601 |
| | The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine | Q34844960 |
| | New vaccines for developing countries: will it be feast or famine? | Q84444922 |
| | In vitro cultivation of Echinococcus granulosus, Taenia hydatigena, T. ovis, T. pisiformis and T. serialis from oncosphere to cystic larva | Q93698214 |
| | Nitazoxanide: an important advance in anti-parasitic therapy | Q28188892 |
| | Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm | Q28238731 |
| | Asthma and current intestinal parasite infection: systematic review and meta-analysis | Q28246448 |
| | The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination | Q28248682 |
| | A plan to defeat neglected tropical diseases | Q28269913 |
| | Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis | Q28277486 |
| | Association between genital schistosomiasis and HIV in rural Zimbabwean women | Q28296559 |
| | Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva | Q28469147 |
| | Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos | Q28743949 |
| | Neglected Diseases Amid Wealth In The United States And Europe | Q29032269 |
| | Hookworm Infection | Q29544757 |
| | Control of neglected tropical diseases | Q29547285 |
| | Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk | Q29547716 |
| | Soil-transmitted helminth infections: updating the global picture | Q29619026 |
| | Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives | Q29619418 |
| | Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis | Q29619819 |
| | Hookworm Vaccines | Q30053761 |
| | The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica | Q30309667 |
| | Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles | Q30425869 |
| | Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children | Q30425921 |
| | Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh | Q30435884 |
| | Multiplex real-time PCR assay using Scorpion probes and DNA capture for genotype-specific detection of Giardia lamblia on fecal samples | Q30436131 |
| | Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon | Q30436915 |
| | Vaccine prospects for amebiasis | Q30438347 |
| | Use of a modified informed consent process among vulnerable patients: a descriptive study | Q30479131 |
| | Ancylostoma secreted protein 2: cloning and characterization of a second member of a family of nematode secreted proteins from Ancylostoma caninum | Q30700909 |
| | Evidence for an association between hookworm infection and cognitive function in Indonesian school children | Q30732146 |
| | Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni | Q30788653 |
| | Visceral leishmaniasis in eastern Africa--current status | Q36882296 |
| | Role of sand fly saliva in human and experimental leishmaniasis: current insights | Q36884480 |
| | Neglected diseases, civil conflicts, and the right to health | Q36914039 |
| | DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo | Q36936145 |
| | Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar | Q36947786 |
| | Renewed hope for a vaccine against the intestinal adult Taenia solium. | Q36961853 |
| | Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine | Q36974519 |
| | Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. | Q37128771 |
| | Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Cryptosporidium parvum infection in vitro | Q37158734 |
| | Sand flies, Leishmania, and transcriptome-borne solutions | Q37162773 |
| | Can visceral leishmaniasis be eliminated from Asia? | Q37204166 |
| | Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model | Q37216479 |
| | Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection | Q37223654 |
| | Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis | Q37229920 |
| | Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease? | Q37234727 |
| | Plants as biofactories | Q37304459 |
| | An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection | Q37326963 |
| | Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice | Q37349230 |
| | Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement | Q37403491 |
| | Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni | Q37450247 |
| | Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens | Q37521740 |
| | Treatment of leprosy in India | Q37626372 |
| | Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific region | Q37771989 |
| | Potency testing for the experimental Na-GST-1 hookworm vaccine | Q37798012 |
| | Developing vaccines to combat hookworm infection and intestinal schistosomiasis | Q37800361 |
| | Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease | Q38370347 |
| | Control of human African trypanosomiasis: back to square one | Q38496534 |
| | Specific cross-protection between Schistosoma bovis and S. haematobium induced by highly irradiated infections in mice | Q38862356 |
| | In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens | Q38866692 |
| | Tsetse fly saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for exposure assessment | Q38879364 |
| | Schistosomiasis vaccine:research to development | Q38905325 |
| | Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals | Q38906805 |
| | Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt | Q38916056 |
| | A new family of giardial cysteine-rich non-VSP protein genes and a novel cyst protein | Q31087387 |
| | Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method | Q31139373 |
| | Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia | Q33222697 |
| | From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library | Q33223107 |
| | Operational challenges in large clinical trials: examples and lessons learned from the gambia pneumococcal vaccine trial | Q33251907 |
| | Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis | Q33308747 |
| | Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva | Q33308759 |
| | Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease | Q33328462 |
| | The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination | Q33372349 |
| | Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania | Q33450546 |
| | The introduction of new vaccines into developing countries. | Q33539104 |
| | Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover | Q33564382 |
| | Parasites and poverty: the case of schistosomiasis | Q33615662 |
| | Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus | Q33769088 |
| | Vaccination against helminth parasites--the ultimate challenge for vaccinologists? | Q33784974 |
| | Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon | Q33799266 |
| | Mosquito feeding modulates Th1 and Th2 cytokines in flavivirus susceptible mice: an effect mimicked by injection of sialokinins, but not demonstrated in flavivirus resistant mice | Q33855321 |
| | Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE. | Q33870336 |
| | Leishmaniasis: current status of vaccine development | Q33941719 |
| | Clinical and experimental advances in treatment of visceral leishmaniasis | Q33982648 |
| | Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection | Q33984588 |
| | Human immune responses to Schistosoma mansoni vaccine candidate antigens | Q34004360 |
| | Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease | Q34008104 |
| | Natural versus drug-induced resistance in Schistosoma mansoni infection | Q34010207 |
| | Fact or hypothesis: concomitant immunity in taeniid cestode infections. | Q34032337 |
| | Allergy, parasites, and the hygiene hypothesis | Q34124658 |
| | Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis | Q34128082 |
| | Cryptosporidiosis. | Q34130836 |
| | The public health importance of hookworm disease | Q34270014 |
| | The molecular revolution in the development of vaccines against ectoparasites | Q34438116 |
| | Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials | Q34438394 |
| | Infections and allergy - helminths, hygiene and host immune regulation | Q34456465 |
| | Hydatid disease in China | Q38955619 |
| | Homologous and heterologous protective immunity to Egyptian strains of Schistosoma mansoni and S. haematobium induced by ultraviolet-irradiated cercariae | Q38967804 |
| | Waterborne infectious diseases--could they be consigned to history? | Q39002261 |
| | Spectrum of disease and relation to place of exposure among ill returned travelers | Q39011352 |
| | Comparative immunology of human and animal models of hookworm infection | Q39013774 |
| | Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum | Q39030027 |
| | Immunization of baboons with attenuated schistosomula of Schistosoma haematobium: levels of protection induced by immunization with larvae irradiated with 20 and 60 krad | Q39051086 |
| | Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania | Q39056535 |
| | Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases | Q39078371 |
| | Neglected tropical disease vaccines | Q39078374 |
| | Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. | Q39096377 |
| | Turning neglected tropical diseases into forgotten maladies | Q39283920 |
| | Seroepidemiology of amebiasis in Mexico | Q39400427 |
| | Schistosoma mansoni and S. japonicum: comparison of levels of ultraviolet irradiation for vaccination of mice with cercariae | Q39414309 |
| | Seroepidemiology of Entamoeba histolytica in a slum in northeastern Brazil | Q39440061 |
| | Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus | Q39594559 |
| | Seeking the ghost of worms past | Q39602856 |
| | Patterns in parasite epidemiology: the peak shift | Q39602864 |
| | Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa | Q39764809 |
| | Industrial Development and Field Use of the Canine Hookworm Vaccine | Q39781740 |
| | Vaccination Against the Canine Hookworm Diseases | Q39998776 |
| | Hydatidosis/Cysticercosis: Immune Mechanisms and Immunization Against Infection | Q40106005 |
| | The present and future of vaccination for cutaneous leishmaniasis | Q40301328 |
| | Present and future control of cryptosporidiosis in humans and animals. | Q40460370 |
| | The global burden of intestinal nematode infections--fifty years on. | Q40493441 |
| | Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China | Q40498833 |
| | T-cell and cytokine responses in leishmaniasis | Q40769758 |
| | Studies on immune responses to larval cestodes in mice. Increased susceptibility of certain mouse strains and hypothymic mice to Taenia taeniaeformis and analysis of passive transfer of resistance with serum | Q40807797 |
| | A single gene change can extend yeast life span: the role of Ras in cellular senescence | Q40844195 |
| | Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus | Q42162237 |
| | Cryptosporidium parvum glycoprotein gp40 localizes to the sporozoite surface by association with gp15. | Q42571297 |
| | The neglected tropical diseases and their devastating health and economic impact on the member nations of the Organisation of the Islamic Conference | Q42582156 |
| | Immunotherapy for drug-refractory mucosal leishmaniasis | Q42598910 |
| | Proteomic analysis of Schistosoma mansoni cercarial secretions | Q46951966 |
| | Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres | Q47337784 |
| | Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine. | Q47587014 |
| | Potency assay design for adjuvanted recombinant proteins as malaria vaccines | Q48030992 |
| | Vaccination against hydatidosis using a defined recombinant antigen | Q48060295 |
| | A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins | Q48226050 |
| | Puberty and Age-related Changes in Susceptibility to Schistosome Infection | Q48546049 |
| | Peace through vaccine diplomacy | Q48864638 |
| | Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. | Q51970673 |
| | Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. | Q52461534 |
| | Disruption of antigenic variation is crucial for effective parasite vaccine. | Q52600029 |
| | Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. | Q52657137 |
| | The role of Product Development Partnerships in research and development for neglected diseases. | Q53173524 |
| | CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein. | Q54048739 |
| | Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report. | Q54311663 |
| | Immunization of rats against Schistosoma mansoni using irradiated cercariae, lung schistosomula and liver-stage worms. | Q54467337 |
| | Influence of Mouse Strain on Induction of Resistance with Irradiated Schistosoma mansoni Cercariae | Q54566432 |
| | Health Innovation Networks to Help Developing Countries Address Neglected Diseases | Q56420403 |
| | Amebiasis | Q56608181 |
| | Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis | Q57392736 |
| | Mass Spectrometric Analysis of theSchistosomamansoniTegumental Sub-proteome | Q57666293 |
| | IN VITRO ONCOSPHERE-KILLING ASSAYS TO DETERMINE IMMUNITY TO THE LARVAE OF TAENIA PISIFORMIS, TAENIA OVIS, TAENIA SAGINATA, AND TAENIA SOLIUM | Q57804912 |
| | Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep | Q57932625 |
| | Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children | Q57940118 |
| | Human African trypanosomiasis (sleeping sickness) | Q58842371 |
| | A Technique for studying the in vitro Effect of Serum on Activated Taeniid Hexacanth Embryos | Q58950915 |
| | Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis | Q59278433 |
| | Protection Against Cutaneous Leishmaniasis Resulting from Bites of Uninfected Sand Flies | Q60211990 |
| | Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN) | Q60227750 |
| | Purification and evaluation of the integral membrane protein H11 as a protective antigen against Haemonchus contortus | Q64215663 |
| | Immunization of Mice with Cobalt-60 Irradiated Schistosoma Mansoni Cercariae * | Q67271983 |
| | The immunological response of the rat to infection with Taenia taeniaeformis. V. Sequence of appearance of protective immunoglobulins and the mechanism of action of 7Sgamma2a antibodies | Q67349463 |
| | Resistance against Schistosoma mansoni induced by immunization of mice with cryopreserved schistosomula | Q67433061 |
| | Schistosoma mansoni: Vaccination of mice with highly X-irradiated cercariae | Q70793489 |
| | Echinococcus granulosus cysts: Early development in vitro in the presence of serum from infected sheep | Q70944418 |
| | Taenia taeniaeformis in mice: protective immunization with oncospheres and their products | Q71185192 |
| | A mechanism to account for mouse strain variation in resistance to the larval cestode, Taenia taeniaeformis | Q71212219 |
| | Amoebiasis | Q73216780 |
| | Reverse vaccinology | Q73514027 |
| | Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment | Q73668677 |
| | Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection | Q74844618 |
| | In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics | Q77353762 |
| | Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii | Q79810793 |
| | Dracunculiasis eradication | Q81204823 |
| | Eradication of Taenia solium cysticercosis: a role for vaccination of pigs | Q84226549 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neglected tropical disease | Q929451 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 237-270 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Vaccines to combat the neglected tropical diseases | |
| P478 | volume | 239 | |